Skip to main content

Table 1 Anti-malarial prescriptions to all patients, presumptive malarial and non-malarial patients.

From: Anti-malarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992–2004)

  no of prescribed AM* % no of patients receiving AM % malarial patients % non-malarial patients§ %
total AM* 73 779 100 53 391 100 39 998 74.9 12 656 23.7
CQ 1 (total) 41 103 55.7 41 103 77.0 29 452 71.7 11 058 26.9
Q 2 (total) 25 546 34.6 25 546 47.8 23 783 93.1 1 570 6.1
CQ+Q 3 16 391 22.2 16 391 30.7 15 608 95.2 717 4.4
SP 4 (total) 3 785 5.1 3 785 7.1 3 275 86.5 487 12.9
AQ 5 (total) 3 335 4.5 3 335 6.2 2 845 85.3 487 14.6
AQ+SP 6 1 828 2.5 1 828 3.4 1 658 90.7 168 9.2
  1. *AM: Anti-malarials, §patients with unknown clinical diagnosis are excluded.
  2. 1CQ (total): total number of chloroquine treatments (CQ prescribed alone and CQ+Q), 2Q (total): total number of quinine treatments (Q prescribed alone and CQ+Q), 3CQ+Q: CQ and Q prescribed together (Q as first treatment and CQ as relay treatment), 4SP (total): total number of sulphadoxine-pyrimethamine treatments, 5AQ (total): total number of amodiaquine treatments, 6AQ+SP: bi-therapy with AQ and SP.